| ■ 영문 제목 : Global Oncology Drugs Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02116 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 122 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 종양 치료용 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (화학 치료, 표적 치료, 면역 치료 (생물학적 치료), 호르몬 치료, 기타)와 용도별 시장규모 (혈액암, 유방암, 위장암, 전립샘암, 호흡기암 및 폐암, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 종양 치료용 약물 시장 점유율 - 지역별 종양 치료용 약물 시장규모 - 주요지역의 종류별 시장규모 (화학 치료, 표적 치료, 면역 치료 (생물학적 치료), 호르몬 치료, 기타) - 주요지역의 용도별 시장규모 (혈액암, 유방암, 위장암, 전립샘암, 호흡기암 및 폐암, 기타) - 미주의 종양 치료용 약물 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 종양 치료용 약물 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 종양 치료용 약물 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 종양 치료용 약물 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 종양 치료용 약물 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Oncology Drugs will have significant change from previous year. By the most conservative estimates of global Oncology Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 174700 million in 2020. Over the next five years the Oncology Drugs market will register a 10.7% CAGR in terms of revenue, the global market size will reach US$ 262210 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
According to the type, the income of chemotherapy is the highest, reaching 51.31% in 2019.
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
According to the application, blood cancer has the highest share of revenue, more than 22 percent in 2019.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
1 Scope of the Report 2 Executive Summary 3 Oncology Drugs Market Size by Players 4 Oncology Drugs by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Oncology Drugs Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Oncology Drugs Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Chemotherapy Table 3. Major Players of Targeted Therapy Table 4. Major Players of Immunotherapy (Biologic Therapy) Table 5. Major Players of Hormonal Therapy Table 6. Major Players of Others Table 7. Oncology Drugs Market Size CAGR by Type (2020-2026) & ($ Millions) Table 8. Global Oncology Drugs Market Size by Type (2016-2021) & ($ Millions) Table 9. Global Oncology Drugs Market Size Market Share by Type (2016-2021) Table 10. Oncology Drugs Market Size CAGR by Application (2016-2021) & ($ Millions) Table 11. Global Oncology Drugs Market Size by Application (2016-2021) & ($ Millions) Table 12. Global Oncology Drugs Market Size Market Share by Application (2016-2021) Table 13. Global Oncology Drugs Revenue by Players (2019-2021E) & ($ Millions) Table 14. Global Oncology Drugs Revenue Market Share by Players (2019-2021E) Table 15. Oncology Drugs Key Players Head office and Products Offered Table 16. Oncology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Oncology Drugs Market Size by Regions 2016-2021 & ($ Millions) Table 20. Global Oncology Drugs Market Size Market Share by Regions 2016-2021 Table 21. Americas Oncology Drugs Market Size by Country (2016-2021) & ($ Millions) Table 22. Americas Oncology Drugs Market Size Market Share by Country (2016-2021) Table 23. Americas Oncology Drugs Market Size by Type (2016-2021) & ($ Millions) Table 24. Americas Oncology Drugs Market Size Market Share by Type (2016-2021) Table 25. Americas Oncology Drugs Market Size by Application (2016-2021) & ($ Millions) Table 26. Americas Oncology Drugs Market Size Market Share by Application (2016-2021) Table 27. APAC Oncology Drugs Market Size by Region (2016-2021) & ($ Millions) Table 28. APAC Oncology Drugs Market Size Market Share by Region (2016-2021) Table 29. APAC Oncology Drugs Market Size by Type (2016-2021) & ($ Millions) Table 30. APAC Oncology Drugs Market Size Market Share by Type (2016-2021) Table 31. APAC Oncology Drugs Market Size by Application (2016-2021) & ($ Millions) Table 32. APAC Oncology Drugs Market Size Market Share by Application (2016-2021) Table 33. Europe Oncology Drugs Market Size by Country (2016-2021) & ($ Millions) Table 34. Europe Oncology Drugs Market Size Market Share by Country (2016-2021) Table 35. Europe Oncology Drugs Market Size by Type (2016-2021) & ($ Millions) Table 36. Europe Oncology Drugs Market Size Market Share by Type (2016-2021) Table 37. Europe Oncology Drugs Market Size by Application (2016-2021) & ($ Millions) Table 38. Europe Oncology Drugs Market Size Market Share by Application (2016-2021) Table 39. Middle East & Africa Oncology Drugs Market Size by Region (2016-2021) & ($ Millions) Table 40. Middle East & Africa Oncology Drugs Market Size Market Share by Region (2016-2021) Table 41. Middle East & Africa Oncology Drugs Market Size by Type (2016-2021) & ($ Millions) Table 42. Middle East & Africa Oncology Drugs Market Size Market Share by Type (2016-2021) Table 43. Middle East & Africa Oncology Drugs Market Size by Application (2016-2021) & ($ Millions) Table 44. Middle East & Africa Oncology Drugs Market Size Market Share by Application (2016-2021) Table 45. Key and Potential Regions of Oncology Drugs Table 46. Key Application and Potential Industries of Oncology Drugs Table 47. Key Challenges of Oncology Drugs Table 48. Key Trends of Oncology Drugs Table 49. Global Oncology Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 50. Global Oncology Drugs Market Size Market Share Forecast by Regions (2021-2026) Table 51. Global Oncology Drugs Market Size Forecast by Type (2021-2026) & ($ Millions) Table 52. Global Oncology Drugs Market Size Market Share Forecast by Type (2021-2026) Table 53. Global Oncology Drugs Market Size Forecast by Application (2021-2026) & ($ Millions) Table 54. Global Oncology Drugs Market Size Market Share Forecast by Application (2021-2026) Table 55. Roche Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 56. Roche Oncology Drugs Product Offered Table 57. Roche Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 58. Roche Main Business Table 59. Roche Latest Developments Table 60. Celgene Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 61. Celgene Oncology Drugs Product Offered Table 62. Celgene Main Business Table 63. Celgene Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 64. Celgene Latest Developments Table 65. Novartis Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 66. Novartis Oncology Drugs Product Offered Table 67. Novartis Main Business Table 68. Novartis Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 69. Novartis Latest Developments Table 70. Bristol-Myers Squibb Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 71. Bristol-Myers Squibb Oncology Drugs Product Offered Table 72. Bristol-Myers Squibb Main Business Table 73. Bristol-Myers Squibb Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 74. Bristol-Myers Squibb Latest Developments Table 75. Johnson & Johnson Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 76. Johnson & Johnson Oncology Drugs Product Offered Table 77. Johnson & Johnson Main Business Table 78. Johnson & Johnson Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 79. Johnson & Johnson Latest Developments Table 80. Merck & Co. Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 81. Merck & Co. Oncology Drugs Product Offered Table 82. Merck & Co. Main Business Table 83. Merck & Co. Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 84. Merck & Co. Latest Developments Table 85. AstraZeneca Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 86. AstraZeneca Oncology Drugs Product Offered Table 87. AstraZeneca Main Business Table 88. AstraZeneca Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 89. AstraZeneca Latest Developments Table 90. Pfizer Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 91. Pfizer Oncology Drugs Product Offered Table 92. Pfizer Main Business Table 93. Pfizer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 94. Pfizer Latest Developments Table 95. Amgen Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 96. Amgen Oncology Drugs Product Offered Table 97. Amgen Main Business Table 98. Amgen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 99. Amgen Latest Developments Table 100. Eli Lilly Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 101. Eli Lilly Oncology Drugs Product Offered Table 102. Eli Lilly Main Business Table 103. Eli Lilly Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 104. Eli Lilly Latest Developments Table 105. AbbVie Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 106. AbbVie Oncology Drugs Product Offered Table 107. AbbVie Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 108. AbbVie Main Business Table 109. AbbVie Latest Developments Table 110. Takeda Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 111. Takeda Oncology Drugs Product Offered Table 112. Takeda Main Business Table 113. Takeda Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 114. Takeda Latest Developments Table 115. Astellas Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 116. Astellas Oncology Drugs Product Offered Table 117. Astellas Main Business Table 118. Astellas Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 119. Astellas Latest Developments Table 120. Ipsen Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 121. Ipsen Oncology Drugs Product Offered Table 122. Ipsen Main Business Table 123. Ipsen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 124. Ipsen Latest Developments Table 125. Sanofi Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 126. Sanofi Oncology Drugs Product Offered Table 127. Sanofi Main Business Table 128. Sanofi Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 129. Sanofi Latest Developments Table 130. Bayer Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 131. Bayer Oncology Drugs Product Offered Table 132. Bayer Main Business Table 133. Bayer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 134. Bayer Latest Developments Table 135. Biogen Idec Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 136. Biogen Idec Oncology Drugs Product Offered Table 137. Biogen Idec Main Business Table 138. Biogen Idec Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 139. Biogen Idec Latest Developments Table 140. Teva Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 141. Teva Oncology Drugs Product Offered Table 142. Teva Main Business Table 143. Teva Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 144. Teva Latest Developments Table 145. Otsuka Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 146. Otsuka Oncology Drugs Product Offered Table 147. Otsuka Main Business Table 148. Otsuka Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 149. Otsuka Latest Developments Table 150. Eisai Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 151. Eisai Oncology Drugs Product Offered Table 152. Eisai Main Business Table 153. Eisai Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 154. Eisai Latest Developments Table 155. Merck KGaA Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 156. Merck KGaA Oncology Drugs Product Offered Table 157. Merck KGaA Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 158. Merck KGaA Main Business Table 159. Merck KGaA Latest Developments Table 160. Gilead Sciences Details, Company Type, Oncology Drugs Area Served and Its Competitors Table 161. Gilead Sciences Oncology Drugs Product Offered Table 162. Gilead Sciences Main Business Table 163. Gilead Sciences Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 164. Gilead Sciences Latest Developments List of Figures Figure 1. Oncology Drugs Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Oncology Drugs Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Oncology Drugs Market Size Market Share by Type in 2020 Figure 7. Oncology Drugs in Blood Cancer Figure 8. Global Oncology Drugs Market: Blood Cancer (2016-2021) & ($ Millions) Figure 9. Oncology Drugs in Breast Cancer Figure 10. Global Oncology Drugs Market: Breast Cancer (2016-2021) & ($ Millions) Figure 11. Oncology Drugs in Gastrointestinal Cancer Figure 12. Global Oncology Drugs Market: Gastrointestinal Cancer (2016-2021) & ($ Millions) Figure 13. Oncology Drugs in Prostate Cancer Figure 14. Global Oncology Drugs Market: Prostate Cancer (2016-2021) & ($ Millions) Figure 15. Oncology Drugs in Respiratory or Lung Cancer Figure 16. Global Oncology Drugs Market: Respiratory or Lung Cancer (2016-2021) & ($ Millions) Figure 17. Oncology Drugs in Others Figure 18. Global Oncology Drugs Market: Others (2016-2021) & ($ Millions) Figure 19. Global Oncology Drugs Market Size Market Share by Application in 2020 Figure 20. Global Oncology Drugs Revenue Market Share by Player in 2020 Figure 21. Global Oncology Drugs Market Size Market Share by Regions (2016-2021) Figure 22. Americas Oncology Drugs Market Size 2016-2021 ($ Millions) Figure 23. APAC Oncology Drugs Market Size 2016-2021 ($ Millions) Figure 24. Europe Oncology Drugs Market Size 2016-2021 ($ Millions) Figure 25. Middle East & Africa Oncology Drugs Market Size 2016-2021 ($ Millions) Figure 26. Americas Oncology Drugs Market Size Market Share by Country in 2020 Figure 27. Americas Oncology Drugs Market Size Market Share by Type in 2020 Figure 28. Americas Oncology Drugs Market Size Market Share by Application in 2020 Figure 29. United States Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 30. Canada Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 31. Mexico Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 32. APAC Oncology Drugs Market Size Market Share by Regions in 2020 Figure 33. APAC Oncology Drugs Market Size Market Share by Type in 2020 Figure 34. APAC Oncology Drugs Market Size Market Share by Application in 2020 Figure 35. China Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 36. Japan Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 37. Korea Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 38. Southeast Asia Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 39. India Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 40. Australia Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 41. Europe Oncology Drugs Market Size Market Share by Country in 2020 Figure 42. Europe Oncology Drugs Market Size Market Share by Type in 2020 Figure 43. Europe Oncology Drugs Market Size Market Share by Application in 2020 Figure 44. Germany Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 45. France Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 46. UK Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 47. Italy Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 48. Russia Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 49. Middle East & Africa Oncology Drugs Market Size Market Share by Region in 2020 Figure 50. Middle East & Africa Oncology Drugs Market Size Market Share by Type in 2020 Figure 51. Middle East & Africa Oncology Drugs Market Size Market Share by Application in 2020 Figure 52. Egypt Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 53. South Africa Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 54. Israel Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 55. Turkey Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 56. GCC Country Oncology Drugs Market Size Growth 2016-2021 ($ Millions) Figure 57. Americas Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 58. APAC Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 59. Europe Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 60. Middle East & Africa Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 61. United States Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 62. Canada Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 63. Mexico Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 64. Brazil Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 65. China Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 66. Japan Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 67. Korea Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 68. Southeast Asia Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 69. India Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 70. Australia Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 71. Germany Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 72. France Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 73. UK Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 74. Italy Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 75. Russia Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 76. Spain Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 77. Egypt Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 78. South Africa Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 79. Israel Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 80. Turkey Oncology Drugs Market Size 2021-2026 ($ Millions) Figure 81. GCC Country Oncology Drugs Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 종양 치료용 약물 시장예측 2021년-2026년] (코드 : LPI-2201K02116) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 종양 치료용 약물 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |